1. Home /
  2. Drug Approvals

Drug Approvals

What's Going On With the Share Price of Gilead?

The charts tell me there's trouble here.

I'm Long Moderna and Here's Why

The focus when it comes to MRNA is the timing of mRNA-1273, the firm's two dose hopeful protection against Covid.

Picking My Spots to Invest My Stash of Cash; Here Are 2 of Them

Kala Pharmaceuticals and Enova International are two companies that have better prospects than the market is pricing in at present.

Surviving in This Environment, Shaky Recovery, Lilly and Pfizer Setbacks

The 'work from home' or 'economic lockdown' trade is close to being back on.

Jim Cramer: I Don't See a Way Out of the Spiral Down Until We Have a Vaccine

We are back to square one except for one positive and one negative.

Election Hopes, Buoyant Banks, Labor Labors Less, FDA's Remdesivir Thumbs Up

Plus, a quick look at Southwest Airlines and why it remains the one airline to own.

Take Advantage of Overblown Healthcare Worries With This Trade

Monday's action in Johnson & Johnson is a fadeable event.

Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade

Covid itself, and therapeutics or vaccines associated with taking on the SARS-CoV-2 coronavirus, is under a public microscope.

Jim Cramer: Here's How We're Going to Beat Covid-19

Let's talk about what's happening right now to get this thing under control and what it will look like not that long from now.

Should You Invest in Regeneron, Lilly, or Gilead?

Invest either because of their profitable portfolio, their impressive pipeline, or their technical set-up.